معرفی
Olivier Gaide is an Associate Professor at the Faculty of Biology and Medicine (FBM) of the University of Lausanne (UNIL), a position he has held since August 1, 2022. He is also affiliated with the Dermatology and Venereology Department at the Lausanne University Hospital (CHUV), where he serves as Head Physician and leads the Onco-dermatology and Interventional Dermatology Unit. His career combines clinical expertise in dermatology with translational research focused on skin cancer and rare genetic skin disorders.
His education includes a Federal Medical Diploma from UNIL (1998), an MD from the University of Zurich (1999), and an MD-PhD in Biology from UNIL (2003). He obtained his specialist title in dermatology and venereology from the Swiss Medical Association (ISFM) in 2008 and completed a visiting scientist fellowship at the Harvard Institute of Medicine (2010–2012). He was a Privat-docent at the University of Geneva (2012–2016) and served as a private lecturer and researcher at UNIL’s FBM from 2014 to 2022.
Olivier Gaide's research is centered on improving early detection of skin cancers using innovative non-invasive microscopy techniques that allow imaging directly on the skin. He has pioneered an in utero drug therapy for hypohidrotic ectodermal dysplasia, with three documented therapeutic successes and an ongoing international study. Additionally, he investigates the impact of electromagnetic radiation, particularly Flash radiotherapy, on skin cancers—a groundbreaking approach in oncology. His clinical work focuses on onco-dermatology and interventional dermatology.
He has held significant leadership roles, including Head of the Onco-dermatology and Interventional Dermatology Unit at CHUV since 2015 and Head Physician since 2021. In 2019, he completed a Micro-MBA at CHUV, reflecting his engagement with healthcare management. No scientific awards or publications are listed in the provided text.
Olivier Gaide has not been mentioned as supervising any students in the available information. He has no listed email addresses. He is actively contributing to both academic and clinical domains without indication of part-time status, retirement, or former staff classification.
